IRON

75.1401.27%
JD

John D. Quisel

CEO, President & Director

Dr. John D. Quisel, J.D., Ph.D., Esq., serves as Independent Director of Gossamer Bio, Inc. since November 2023. He serves as Chief Executive Officer of Disc Medicine, Inc. since February 25, 2020 and serves as its President. He serves as Director at Disc Medicine, Inc. since February 2020 and served as its Secretary. He joined Disc Medicine, Inc. on February 25, 2020. Dr. Quisel is Atlas Advisor of Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). from 2025. He served as Executive Vice President and Chief Business Officer of Acceleron Pharma Inc. since May 10, 2018 until February 24, 2020 and served as its Secretary. Dr. Quisel served as Senior Vice President of Corporate Development at Acceleron Pharma Inc. from July 20, 2017 to May 10, 2018 and as its General Counsel until May 10, 2018. Dr. Quisel served as Senior Vice President of Business Development of Acceleron Pharma, Inc. from April 28, 2016 to July 20, 2017. Dr. Quisel served as Secretary at Acceleron Pharma, Inc. until April 28, 2016. Dr. Quisel served as Vice President of Acceleron Pharma, Inc until June 20, 2014 and served as its Senior Vice President from June 20, 2014 to April 28, 2016. Dr. Quisel established the Acceleron Pharma's intellectual property, in-licensing, compliance and corporate governance functions. Since joining Acceleron in October 2006, Dr. Quisel has held a variety of roles spanning legal, intellectual property, business development and research strategy. His experience spans many aspects of biotechnology law, including the negotiation of intellectual property licenses and product development collaborations, patent prosecution and litigation. As Head of Legal, Dr. Quisel supported and negotiated venture capital financings, the Acceleron Pharma's 2013 IPO and subsequent public offerings, in addition to the negotiation of collaboration and licensing agreements with Celgene Corp., Shire Plc and many academic institutions. Prior to joining Acceleron, he worked at the Boston office of Ropes & Gray LLP and prior to that, the Boston office of Foley Hoag LLP. In his capacity as external counsel, Dr. Quisel has, through strategic in-licensing and protection of internal research programs, assembled and licensed product and platform focused intellectual property portfolios for numerous biotechnology ventures. He holds an A.B. in Biology from Harvard University, an M.S. in biology from Stanford University, a Ph.D. in biology from Massachusetts Institute of Technology (M.I.T.) and a J.D. from Harvard Law School.

公司职务